Multifocal tuberculosis on certolizumab pegol in a patient followed for rheumatoid arthritis.
TNF inhibitor
certolizumab pegol
rheumatoid arthritis
tuberculosis
Journal
Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
received:
02
04
2021
accepted:
27
04
2021
entrez:
17
6
2021
pubmed:
18
6
2021
medline:
18
6
2021
Statut:
epublish
Résumé
Tuberculosis must be considered in front of deterioration in general condition in patient with rheumatic disease under biological therapy. Rheumatologists may pay attention and screen infections before and after prescribing biological therapy.
Identifiants
pubmed: 34136240
doi: 10.1002/ccr3.4307
pii: CCR34307
pmc: PMC8190679
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e04307Informations de copyright
© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Déclaration de conflit d'intérêts
None declared.
Références
Rev Mal Respir. 2008 Dec;25(10):1237-49
pubmed: 19107015
PLoS One. 2017 Nov 28;12(11):e0188631
pubmed: 29182688
Clin Chest Med. 2019 Dec;40(4):721-739
pubmed: 31731980
Rheumatology (Oxford). 2019 May 1;58(5):803-810
pubmed: 30561745
Autoimmun Rev. 2012 Dec;12(2):225-9
pubmed: 22796281
BMJ Open. 2017 Mar 22;7(3):e012567
pubmed: 28336735
N Engl J Med. 2001 Oct 11;345(15):1098-104
pubmed: 11596589
J Microbiol Immunol Infect. 2014 Aug;47(4):268-74
pubmed: 23727394